Mousepox, a small animal model of smallpox

Methods in Molecular Biology

Volumn 890, Issue , 2012, Pages 177-198

  Esteban, David ^a   Parker, Scott ^b   Schriewer, Jill ^b   Hartzler, Hollyce ^b   Buller, R Mark ^b  

^a VASSAR COLLEGE   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Animal model; Ectromelia virus; Host response; Infection; Mouse; Poxvirus

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE MODEL; ECTROMELIA VIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL MOUSE; INOCULATION; MOUSE; MOUSEPOX; NONHUMAN; ORTHOPOXVIRUS; PRIORITY JOURNAL; SMALLPOX; TISSUE SECTION; VIRUS IMMUNITY; VIRUS NEUTRALIZATION; ANIMAL; ANIMAL EUTHANASIA; ANIMAL HUSBANDRY; C57BL MOUSE; CELL LINE; GROWTH, DEVELOPMENT AND AGING; HAZARDOUS WASTE; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; LYMPHOCYTE COUNT; METABOLISM; PATHOLOGY; SECRETION; VIROLOGY; VIRUS CULTURE; VIRUS LOAD;

GAMMA INTERFERON; VIRUS ANTIBODY;

ANIMAL HUSBANDRY; ANIMALS; ANTIBODIES, VIRAL; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CONTAINMENT OF BIOHAZARDS; DISEASE MODELS, ANIMAL; ECTROMELIA VIRUS; ECTROMELIA, INFECTIOUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EUTHANASIA, ANIMAL; HUMANS; INTERFERON-GAMMA; LYMPHOCYTE COUNT; MICE; MICE, INBRED C57BL; SMALLPOX; VIRAL LOAD; VIRAL PLAQUE ASSAY; VIRUS CULTIVATION;

EID: 84866787456     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-876-4_11     Document Type: Article

References (22)

1. Parker S, Nuara A, Buller RML, Schultz DA (2007) Human monkeypox: an emerging zoonotic disease. Future Microbiol 2:17-34
2. Henderson DA (1999) The looming threat of bioterrorism. Science 283:1279-82
3. Fenner F, Henderson DA, Arita I, Jezek Z, Ladnyi ID (1988) Smallpox and its eradication. World Health Organization, Geneva
4. Saini D, Buller RM, Biris AS, Biswas P (2009) Characterization of a nose-only Inhalation exposure system for ectromelia virus infection of mice. Particulate Sci Technol 27: 152-65
5. Hostetler KY, Beadle JR, Trahan J et al (2007) Oral 1-O-octadecyl-2-O- benzyl-sn-glycero-3-cidofovir targets the lung and is effective against a lethal respiratory challenge with ectromelia virus in mice. Antiviral Res 73:212-8
6. Parker AK, Parker S, Yokoyama WM, Corbett JA, Buller RML (2007) Induction of natural killer cell responses by ectromelia virus controls infection. J Virol 81:4070-9
7. Buller RML, Fenner F (2007) Mousepox. In: Fox JG, Barthold SW, Davisson MT, Newcomer CE, Quimby FW, Smith AL (eds) The mouse in biomedical research. Elsevier, New York, pp 67-92
8. Esteban DJ, Buller RML (2005) Ectromelia virus: the causative agent of mousepox. J Gen Virol 86:2645-59
9. Palumbo GJ, Buller RML (1991) Inhibitors of the lipoxygenase pathway speci fically block orthopoxvirus replication. Virology 180: 457-63
10. Brownstein DG, Bhatt PN, Gras L, Jacoby RO (1991) Chromosomal locations and gonadal dependence of genes that mediate resistance to ectromelia (mousepox) virus-induced mortality. J Virol 65:1946-51
11. Delano ML, Brownstein DG (1995) Innate resistance to lethal mousepox is genetically linked to the NK gene complex on chromosome 6 and correlates with early restriction of virus replication by cells with an NK phenotype. J Virol 69:5875-7
12. Brownstein DG, Gras L (1997) Differential pathogenesis of lethal mousepox in congenic DBA/2 mice implicates natural killer cell receptor NKR-P1 in necrotizing hepatitis and the fifth component of complement in recruitment of circulating leukocytes to spleen. Am J Pathol 150:1407-20
13. Schell K (1960) Studies on the innate resistance of mice to infection with mousepox. II. Route of inoculation and resistance, and some observations on the inheritance of resistance. Aust J Exp Biol Med Sci 38:289-99
14. Jacoby RO, Bhatt PN (1987) Mousepox in inbred mice innately resistant or susceptible to lethal infection with ectromelia virus. II. Pathogenesis. Lab Anim Sci 37:16-22
15. Bhatt PN, Jacoby RO (1987) Mousepox in inbred mice innately resistant or susceptible to lethal infection with ectromelia virus. I. Clinical responses. Lab Anim Sci 37:11-5
16. Bhatt PN, Jacoby RO, Gras L (1988) Mousepox in inbred mice innately resistant or susceptible to lethal infection with ectromelia virus. IV. Studies with the Moscow strain. Arch Virol 100:221-30
17. Wallace GD, Buller RM (1985) Kinetics of ectromelia virus (mousepox) transmission and clinical response in C57BL/6j. BALB/cByj and AKR/J inbred mice. Lab Anim Sci 35:41-6
18. Wallace GD, Buller RML, Morse HC III (1985) Genetic determinants of resistance to ectrome-lia (mousepox) virus-induced mortality. J Virol 55:890-1
19. Schriewer J, Buller RM, Owens G (2004) Mouse models for studying orthopoxvirus respiratory infections. Methods Mol Biol 269: 289-308
20. Earl PL, Moss B, Wyatt LS, Carroll MW (2001) Generation of recombinant vaccinia viruses, Chapter 16. In: Ausubel FM (ed) Current protocols in molecular biology
21. Forbes N, Brayton C, Grindle S, Shepherd S, Tyler B, Guarnieri M (2010) Morbidity and mortality rates associated with serial bleeding from the super ficial temporal vein in mice. Lab Anim (NY) 39:236-40
22. Zhang Z, Kermekchiev MB, Barnes WM (2010) Direct DNA ampli fication from crude clinical samples using a PCR enhancer cocktail and novel mutants of Taq. J Mol Diagn 12:152-61